Skip to content
Screener

Discontinued — last reported Q4 '25

Free cash flow at other companies

Pfizer logo
PfizerPFE
$2.18B+23.0%
Sionna Therapeutics logo
Sionna TherapeuticsSION
-$21.84M-33.4%
Ispire Technology Inc. logo
Ispire Technology Inc.ISPR
-$4.04M
Philip Morris International logo
Philip Morris InternationalPM
$5.11B+67.3%

Other financials

Income statement

See full
Net income-$10.2M+20.7%
EPS (diluted)-$0.19+48.6%

Balance sheet

See full
Cash & equivalents$28.1M+116%
Total debt$5.6M+332%
Total equity$10.7M+3.9%
Total assets$33.1M+21.0%

Cash flow

See full
Operating cash flow-$6.9M+37.5%
CapEx$750.0

Valuation

See full
Market cap$851M+459%
Enterprise value$828.56M+715%

Returns & leverage

See full
Return on equity-496.1%-906pp
Debt / equity0.5×+0.4×
Current ratio2.6×-0.9×

Where this comes from

Calculated from Achieve Life Sciences’s reported figures.

The source filing: Achieve Life Sciences’s 10-K, filed March 24, 2026. Open the filing →

Filed
Mar 24, 2026, 7:10 AM EDT
Fiscal year
FY2025
Accession
0001193125-26-120690

FAQ

What is Achieve Life Sciences's free cash flow?
Achieve Life Sciences (ACHV) reported free cash flow of -$12.37M in Q4 2025.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.

Ask your AI about Achieve Life Sciences's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude